With MedLinX, I both work with clients independently and partner with other boutique consulting firms to deliver work within the Healthcare / Life Sciences & Medtech Industry. Past work includes:* Data strategy for Direct-to-Consumer Patient Engagement for a Pharma Client* Strategy development approach and facilitation for local non-profit* Customized Market Research for ear-tube placement technology startup* Business Plan and Product Strategy for wound closure startup*10th investor in MinuteClinic (as QuickMed, before it was bought by CVS)

Defined business strategies to improve Pharma R&D, Commercialization, and Operations.• Optimized the Health Care Professional CX to drive adoption at the launch of a new rare disease drug• Maximized potential business impact of Intelligent Automation with x-func strategy and prioritization• Developed Business Engagement workshops to id transformational solutions enabled by Cloud technology

Developed Digital Transformation strategies for Pharma clients to maximize R&D effectiveness.• Defined new Clinical Data Platform strategy, including Vendor RFI/RFP and roadmaps, to realize new data capabilities as well as to optimize technology investment and operational savings• Conducted due diligence assessment for a new Digital Pathology solution with potential for $millions in R&D productivity, ensuring it would meet the needs of enterprise-wide stakeholders for large pharma merger

Growth Strategy for Health Plans and Providers:• Enabled expanded capacity and projected $1.5 million / year in operational efficiency through a Health Plan Enrollment Modernization strategy engagement employing BPR, Design Thinking for new UX, and Simulation • Unlocked growth potential for major Provider through refreshed Digital Strategy and Op ModelDigital Transformation Strategy for Insurance Companies:• Enabled commercial insurance Agents to provide quote for coverage and secure business at initial customer visit using a digital strategy for "Straight-Thru" underwriting• Optimized the Core Admin Platform for 2 merging insurance companies, saving >$25 million in tech spendGo-to-Market Strategies for Insurance Intermediary and Health Plan:• Ensured profitable growth by developing pricing model for Chiropractic Fiscal Intermediary • Maximized potential for Medicaid state health plan contract selection by facilitating response to RFP

Enabled Clinician innovation to provide more effective, engaging patient care models and to better meet Quality Metrics.• Using Stanford/IDEO Human Centered Design methodology, led Design Thinking workshops and innovation pilots for Asthma, Medication Adherence, Diabetes & Transport• Developed and introduced Innovation System - Portfolio, Process, Leadership, Team Structure, & Metrics

Founded MedLinX to provide business consulting for healthcare/medtech companies.
• Developed product strategies and business plans for multiple startups, including ear tube placement tech, blood coagulation therapy, robots for PT innovation, health plan innovation portfolio, and a number of other engagements.
• Private placement investor #10 in "QuickMed," which became MinuteClinic when bought by CVS

• Developed and taught a Medtech industry course in the evening MBA program. Incorporated guest speakers and student projects to develop practical skills.• Also developed online training courses for World Medical Device Organization (WMDO.org) on Creating Value in Healthcare, Developing Markets for Medical Technologies, and Business Plan Essentials

Joined Merrill Lynch for a career change to be a financial advisor and to grow a practice in the firm.• Earned Series 7, 66, and Insurance licenses and Certified Financial Planner (CFP) designation• Developed client base. Experienced the housing market crash of 2008

Hired to leverage experience as an Innovation Consultant to develop and lead the cross-functional, multi-level technology strategy and portfolio management process, building a brand-new product planning department for the company.• Drove strategy to invest in remote patient follow-up and HF mgmt (Kellogg b-school case study)• Earned a Patent: Method & Apparatus for Anti-Tachycardia Pacing and Defibrillation

Objective to define path for growth from new therapies and indications for implanted neurostimulators.• Led Spinal Cord Stimulation Venture, visiting European investigators and identifying key business risks for program• Facilitated strategic planning forums across the 50-person Leadership team with the NeuroStimulation VP

Boutique consulting firm using academic affiliate model. Founded by HBS professors Kim Clark and Steven Wheelwright.• Consulted on Innovation and Operations Re-Engineering to improve return on R&D across industries: healthcare, hospital equipment, industrial tools & equipment, semiconductors, financial services.• Operational effectiveness and business process re-engineering for Fast Cycle time.

• Implemented pre-market-release clinical studies for FDA approval across 5 states for pacemaker & defibrillator product lines. First site for indwelling CHF monitor.• International internship at the Bakken Research Center, Maastricht, the Netherlands.